- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02591706
Clinical Assessment of Dental Implant (H2015-1)
Clinical and Radiographic Assessment of V3 Implant: A Randomized Controlled Trial
Primary Endpoints : The implant survival and success rate of V3 and C1 implants will be compared. Implant success rate will be evaluated by measuring the peri-implant bone remodeling from baseline to 1 year post insertion.
The hypothesis is those implant survival rates of the test (V3) and control group (C1) are similar and that test V3 implant allows less peri-implant bone loss.
Secondary Endpoints : The thickness of hard tissue in the buccal aspect of the V3 and C1 implants will be compared. The bone thickness will be measured in cone beam computerized tomography (CBCT) on the day of implantation, 4 and at one year after the final restoration.
The hypothesis is that V3 implant allows thicker bone dimension in the cervical area.
Study Overview
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Liège, Belgium, 4000
- CHU de Liège - Service de Médecine Dentaire
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Subject must have voluntarily signed the informed consent form before any study related action
- Age: 18 with one or more missing teeth in the maxillary area, seeking for implant therapy.
- Men/Women
- In good systemic health (ASA I/ II)
- Present with no contra indication against oral surgical interventions
- Patients required replacement of a single missing tooth. The tooth at the implant site(s) must have been extracted or lost at least 12 weeks before the date of implantation.
- At least 10 mm of bone in the vertical dimension
- At least 6 mm of bone in the bucco-lingual dimension.
- No need for bone augmentation procedure in any of the dimensions
- Full mouth plaque score (FMPI) lower or equal than 25%
Exclusion Criteria:
- Autoimmune disease require medical treatment
- Medical conditions requiring prolonged use of steroids
- Use of Bisphosphonate intravenously or more then
- Infection (local or systemic) - patient with gingivitis or active local infection will undergo a medical treatment prior to his entrance to the study, each individual will be evaluated prior to study procedure for suitability, in case of systemic infection the evaluation will be based on medical anamneses, and if necessary will be referred to relevant medical tests.
- Current pregnancy or breastfeeding women
- Alcoholism or chronically drug abuse
- Immunocompromised patients
- Uncontrolled Diabetes
- Smokers
- Prisoners
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Dental implant (C1)
Internal Conical Connection: The C1 has a six-position cone index, except for the C1 narrow platform that has a four-position cone index. The conical connection is 2.00mm in depth, with a 12° cone. As a result of our meticulous manufacturing process a perfect fit between the implant and the abutment is achieved, eliminating micro-movements and minimizing bone resorption. Patient will be randomly assigned to one of the two groups after flap opening. |
The implantation procedure will be carried out according to a standard surgical protocol, and according the manufacture protocol.
Patient will be randomly assigned to one of the two groups after flap opening.
The implant stability will be measured using the wench key and recorded in N/cm.
The implants will be covered with healing abutments for trans-gingival healing for a period of 4 months.
The area will be sutured with thin nylon sutures for a primary passive fit closure.
Immediately after the surgery the patient will perform a CBCT of the treated area with a cotton roll on the buccal side in order to be able to evaluate the buccal soft tissue thickness.
Other Names:
|
Experimental: Dental implant (V3)
The unique triangular shape of the coronal portion of the V3 implant results in less titanium and more bone and soft tissue visible in the esthetic zone, for a restorative-driven approach and easier soft tissue management. The V3 provides doctors with a more advantageous starting point; where greater volume of bone and soft tissue is achieved at the onset of implant placement. Patient will be randomly assigned to one of the two groups after flap opening. |
The implantation procedure will be carried out according to a standard surgical protocol, and according the manufacture protocol.
Patient will be randomly assigned to one of the two groups after flap opening.
The implant stability will be measured using the wench key and recorded in N/cm.
The implants will be covered with healing abutments for trans-gingival healing for a period of 4 months.
The area will be sutured with thin nylon sutures for a primary passive fit closure.
Immediately after the surgery the patient will perform a CBCT of the treated area with a cotton roll on the buccal side in order to be able to evaluate the buccal soft tissue thickness.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Comparison of implant survival and success rate of V3 and C1 implants
Time Frame: 1 year
|
Implant success rate will be evaluated by measuring the peri-implant bone remodeling from baseline to 1 year post insertion.
The hypothesis is those implant survival rates of the test (V3) and similar and that test V3 implant allows less peri-implant bone loss.
|
1 year
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Comparison of the thickness of hard tissue in the buccal aspect of the V3 and C1 implants
Time Frame: 1 year
|
The bone thickness will be measured in cone beam computerized tomography (CBCT) on the day of implantation, 4 and at one year after the final restoration.
|
1 year
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Measurement of aesthetic outcomes based on the pink esthetic score
Time Frame: 1 year
|
The mesial papilla, distal papilla, soft tissue level, soft tissue contour, alveolar process deficiency, soft tissue color and texture will be assessed at baseline (crown placement) and at 1 year after the final restoration by using the Pink Esthetics Score (PES).
|
1 year
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Study Director: France LAMBERT, University of Liège
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- H2015-1
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Tooth Loss
-
Institut Straumann AGCompleted
-
University of AarhusCompleted
-
Duygu KarasanHacettepe UniversityCompleted
-
Assistance Publique - Hôpitaux de ParisUnknown
-
Cairo UniversityNot yet recruitingLoss of Teeth Due to ExtractionEgypt
-
Eisenhower Army Medical CenterUnknownLoss of Teeth Due to ExtractionUnited States
-
The University of Texas Health Science Center at...Osteogenics BiomedicalCompletedLoss of Teeth Due to Extraction
-
Institut Straumann AGTerminated
-
Heidelberg UniversityCompletedTooth Loss, Teeth Replaced Using All Ceramic FPDsGermany
-
Inesa AstramskaitėCompletedAnxiety | Fear | Teeth, Impacted | Tooth-lossLithuania
Clinical Trials on MIS Implants
-
Blood Transfusion Centre of SloveniaUnknownPancreatic Tubular AdenocarcinomaSlovenia
-
Smith & Nephew, Inc.Completed
-
The University of Texas Health Science Center,...Centers for Disease Control and PreventionNot yet recruitingCancer PreventionUnited States
-
Third Affiliated Hospital, Sun Yat-Sen UniversityNot yet recruiting
-
University of CalgaryAlberta Innovates Health Solutions; Wave View ImagingNot yet recruitingHealthy | Breast
-
Rambam Health Care CampusCompletedFailure of Osseointegration of Dental ImplantIsrael
-
Ain Shams UniversityCompletedCompletely Edentulous PatientsEgypt
-
Tang-Du HospitalNot yet recruiting
-
Shanghai Ninth People's Hospital Affiliated to...Completed